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Tuberculosis (TB) is a common opportunistic infection and the leading cause of death
for human immunodeficiency virus (HIV)-infected patients. Thus, it is necessary to
understand the pathogenetic interactions between M.tb and HIV infection. In this
study, we examined M.tb and/or simian immunodeficiency virus (SIV) infection of
Chinese rhesus macaques. While there was little evidence that M.tb enhanced SIV
infection of macaques, SIV could facilitate M.tb infection as demonstrated by X-rays,
pathological and microbiological findings. Chest X-rays showed that co-infected animals
had disseminated lesions in both left and right lungs, while M.tb mono-infected animals
displayed the lesions only in right lungs. Necropsy of co-infected animals revealed a
disseminated M.tb infection not only in the lungs but also in the extrapulmonary organs
including spleen, pancreas, liver, kidney, and heart. The bacterial counts in the lungs,
the bronchial lymph nodes, and the extrapulmonary organs of co-infected animals were
significantly higher than those of M.tb mono-infected animals. The mechanistic studies
demonstrated that two of three co-infected animals had lower levels of M.tb specific
IFN-γ and IL-22 in PBMCs than M.tb mono-infected animals. These findings suggest
that Chinese rhesus macaque is a suitable and alternative non-human primate model for
SIV/M.tb coinfection studies. The impairment of the specific anti-TB immunity is likely to
be a contributor of SIV-mediated enhancement M.tb infection.
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INTRODUCTION
Mycobacterium tuberculosis (M.tb) and human immunodeficiency virus (HIV) remain severe dual-
epidemics globally. In 2014, an estimated 9.6 million people worldwide suffered from active
tuberculosis (TB) and more than 34 million people were living with HIV (WHO, 2015). M.tb
and HIV have been closely linked since the emergence of acquired immune deficiency syndrome
(AIDS). Among the 9.6 million new TB infections worldwide, 1.2 million (13%) were HIV
seropositive. In addition, HIV-infected individuals who are also infected withM.tb are much more
likely to develop severe TB disease than those who are HIV negative. Of the 1.5 million died
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from TB in 2014, 0.4 million were co-infected with HIV (∼27%)
(WHO, 2015). Although HIV-related TB is both treatable
and preventable, incidence continues to climb in developing
countries where resources are limited. In addition, clinical
data suggested that coinfection with HIV and M.tb increases
progression of both diseases. Thus, it is of importance to
understand the pathogenic interactions betweenM.tb and HIV.
The lack of insight about the interplays between HIV andM.tb
is partially due to the absence of effective experimental animal
models and difficulties in human studies (Mehra et al., 2011).
Although small animals such as mice can be infected by M.tb,
they are not the hosts of HIV. In contrast, nonhuman primates
(NHP), such as Macaca (macaques: rhesus, cynomolgus), are
susceptible to infection by simian immunodeficiency virus (SIV),
a retrovirus similar to HIV, and can develop AIDS (Zhou et al.,
2013). The SIV macaque models have been extensively used
for HIV/AIDS research (Zhou et al., 2013). As a mainstay of
NHP model of HIV/SIV research, Indian rhesus macaques have
contributed greatly to our understanding of HIV disease. Indian
rhesus macaques have been used to study the impact of SIV
infection on M.tb infection (Safi et al., 2003; Mehra et al., 2011).
However, the Indian rhesus macaque model has its limitations.
For example, SIV-infected Indian rhesus macaques develop AIDS
shortly after infection. In contrast, SIV-infected macaques of
Chinese origin survived longer than Indian rhesus macaques
(Ling et al., 2002; Burdo et al., 2005; Cumont et al., 2008; Zhou
et al., 2013).
Macaques are also a good model for TB studies, as they
can be infected by M.tb, progressing to TB disease that closely
resembles the various manifestations of human TB (Capuano
et al., 2003; Peña and Ho, 2015). Similar to human M.tb
infection, infected macaques can develop acute TB or maintain
TB latency for years (Gormus et al., 2004). Therefore, macaques
are suitable for TB/HIV coinfection studies. There have been
several studies using the macaque models (rhesus, pigtail or
cynomolgus species) forM.tb/SIV coinfection studies (Shen et al.,
2001, 2002; Diedrich et al., 2010; Mehra et al., 2011). These
studies demonstrated that latently infected macaques with high-
dose BCG (Shen et al., 2001, 2002) or low-dose Erdman or
CD1551 strains (Diedrich et al., 2010; Mehra et al., 2011) could
have TB reactivation when co-infected with SIV. While these
findings are important in mimicking one aspect of HIV/M.tb
coinfection, e.g.,M.tb infection first and then SIV infection, there
is still need to examine whether SIV infection facilitates M.tb
infection and development of severe TB disease. In the present
study, we used SIV-infected Chinese rhesus macaques to study
the impact of SIV onM.tb infection.
MATERIALS AND METHODS
Ethics Statement
All animals in this study were housed at the Animal Bio-
Safety Level III (ABSL-III) Laboratory of Wuhan University
School of Medicine. All housing and animal care procedures
were in compliance with the China laws on animal experiments
(Laboratory animal–Requirements of environment an housing
facilities GB14925-2010, China; Regulations on administration of
laboratory animals, Ministry of Science and Technology, 1988,
China) andwith the 8th Guide for the Care andUse of Laboratory
Animals of Association (Committee for the Update of the Guide
for the Care and Use of Laboratory Animals, 2011). The ABSL-
III Laboratory is certified by the Association for Assessment
and Accreditation of Laboratory Animal Care (AAALAC)
International. All study protocols and procedures were approved
by the Institutional Animal Care andUse Committee (IACUC) of
Wuhan University School of Medicine prior to the experiments.
All experimental procedures were performed under anesthesia
with intramuscular injection of ketamine hydrochloride (10
mg/kg) and atropine (0.04 mg/kg), and all efforts were made
to minimize suffering of the study animals. We followed the
guidelines for humane euthanasia of rhesus macaques, and the
re-defined humane endpoints including marked lethargy, severe
dyspnea at rest, hemoptysis and loss of 25% body weight in 3
consecutive weeks compared to the body weight prior to M.tb
infection. If any one of these conditions was present in the study
animals, a humane endpoint was determined and the animals
were euthanized within 24 h.
Experimental Animals
Nine Chinese origin female rhesus macaques (M. mulatta) of 5–6
years old were used for this study. The animals were purchased
from Sichun Yibin Non-Human Primates Breeding and Research
Center, Sichuan, China. These animals were strictly screened by
an independent testing laboratory VRL Animal Health Services
(AHS) to ensure that they were free of simian retrovirus D, SIV,
simian T leukemia virus type 1 (STLV-1) and herpes virus B. In
addition, the animals were quarantined for 90 days and tested
by tuberculin skin test (TST) to ensure that they were free of
M.tb prior to infection. The animals were individually housed in
stainless steel wire-bottomed cages (80× 80× 85 cm dimension)
with sufficient space supplied with a commercial monkey diet and
water and twice daily with fresh fruit in an air-conditioned room
and monitored by a computer-based system. After SIV or M.tb
inoculation, all the study animals were transferred to the negative
pressure rooms and individually housed in the negative pressure
cages (isolators). These measurement ensured that the animals
were not infecting each other.
SIV and/or M.tb Infection
The experimental designs of SIV and/or M.tb infection are
described in Table 1. SIVmac239 strain was obtained from
AIDS Research & Reference Reagent Program (Contributor: Dr.
Ronald Desrosiers) of the National Institutes of Health (Bethesda,
MD). M.tb H37Rv strain was obtained from the Research
Institute of Tuberculosis (Tokyo, Japan). Six animals were
intravenously inoculated with 0.5 mL of SIVmac239 (1.5 × 103
TCID50) (Bao et al., 2014). Six weeks after SIV infection, three
SIV mono-infected animals and three SIV uninfected animals
were inoculated with M.tb H37Rv at the dose of 34 colony
forming unit (CFU) by bronchoscopic instillation as described
(Zhang et al., 2011). The plasma SIV RNAs were quantified by
real-time PCR with the primers of SIV GAG gene as described
(Bao et al., 2014; Liu et al., 2016).
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TABLE 1 | Experimental design for SIV and/or M.tb infection.
Group Animal ID Gender Age
(Year)
Weight
(kg)
SIVmac239 (i.v.*)
At Week 0
H37Rv (i.t.*)
At Week 6
Week of Necropsy
(After M.tb infection)
SIV + M.tb WSP1 Female 5.4 5.86 + + 16
WSP2 Female 5.0 5.07 + + 19
WSP3 Female 6.1 6.00 + + 18
SIV WSP4 Female 5.0 5.36 + - NA
WSP5 Female 5.3 5.89 + - NA
WSP6 Female 5.1 5.03 + - NA
M.tb WSP7 Female 6.3 5.15 - + NA
WSP8 Female 5.0 5.20 - + 25
WSP9 Female 6.0 5.15 - + 22
*i.v., intravenous injection; *i.t., intratracheal instillation; NA, not available. SIVmac239 (1.5 ×103 TCID50) in PBS (1 mL) was intravenously introduced into six animals at week 0. Six
weeks later, three of the six SIV-infected animals and three uninfected animals were inoculated with M.tb H37Rv (34 CFU) by intratracheal instillation.
Clinical Evaluation and Chest X-Rays
All the study animals were observed daily for appetite and
every 2 or 3 weeks for body temperature and weight based
on the score system described previously (Zhang et al., 2014).
Appetite was scored daily by the amount of food taken per
meal (2 = all; 1 = about half; 0 = none). A maximum appetite
scores that an animal could achieve were 6 points per day
and 42 points per week, which was defined as 100%. Blood
samples collected from the animals were used for CRP (C-
reactive protein), ESR (Erythrocyte sedimentation rate), flow
cytometry and immunologic assays. ESR was measured by
LENA (Linear chemicals, SL) system, CRP was determined
by Biochemistry Analyzer (Hitachi 7080, Hitachi, Japan) with
the reagents from Wako Pure Chemical Industries (Osaka,
Japan). Chest X-rays were performed by a digital X-ray unit
(SIEMENS Multimobil 2.5, Mobile 810 DDR system, and
PiViewSTAR Workstation System). Evaluation of X-ray findings
was performed by two radiologists with double-blind peer
review.
Flow Cytometry Analyses of CD4+ and
CD8+ T Cells
The CD4/CD8 ratios in peripheral blood were evaluated by
flow cytometry using the fluorochrome labeled monoclonal
antibodies: CD3-FITC (clone SP34; BD Pharmingen);
CD4-PerCP (clone L200; BD Pharmingen); and CD8-PE
(clone RPA-T8; BD Pharmingen). Antibodies, diluted as per
manufacturer’s instructions, were added to 100 µL of EDTA-
whole blood and incubated for 30 min at room temperature.
Erythrocytes were then lysed by BD FACS lysing solution
(Becton, Dickinson). Cells were washed once with 1× PBS
and resuspended in 1× PBS containing 1% paraformaldehyde.
Unstained and single color control samples were acquired to
calculate the compensation matrix. Gating was performed on
mononuclear cells and then on CD3+CD4+ or CD3+CD8+
subpopulations. The flow cytometry analysis was performed
on a BD FACSCalibur (Becton Dickinson Biosciences, San
Jose, CA) and analyzed using CellQuest software (Becton
Dickinson).
ELISpot Assay
96-well multiscreen-immunoprecipitation filtration plates
(Millipore Corp., Bedford, MA) were hydrated with 70%
ethanol, followed by washing with 1× PBS three times, then
coated with anti-human/macaque IFN-γ monoclonal antibody
(U-Cytech Biosciences, Utrecht, The Netherlands) at 4◦C for
24 h prior to the ELISpot assay (U-Cytech Biosciences). Blood
from study animals was collected in heparin CPT Vacutainer
tubes (Becton Dickinson Vacutainer Systems, Franklin Lakes,
NJ) and centrifuged at 1750× g for 30 min. The upper layer
of peripheral blood mononuclear cells (PBMCs) was collected
and washed twice with RPMI 1640 medium supplemented with
1% FBS (Gibco, Life Technologies). Freshly isolated PBMCs
were resuspended at 1 × 106 cells/mL in ELISpot medium
(RPMI 1640 medium supplemented with 10% FBS) and added
into the plates at 3 × 105 cells/well. Cells were stimulated
with PPD (10µg/mL) from M.tb or concanavalin A (ConA,
5 µg/mL; Sigma, St. Louis, MO) or ELISpot medium only in
duplicate wells for 24 h in 5% CO2 air at 37
◦C. PPD were
prepared as described (Landi and Held, 1965; Brel et al., 1995).
The numbers of spots were counted by an ELISPOT reader
(Bioreader 4000, BIOSYS, Germany) and data are reported
as the number of spot-forming units (SFUs) per million
PBMCs.
Real-Time RT-PCR
The above isolated PBMCs were also treated with 10 µg/mL of
PPD for 16 h at 37◦C in a 5% CO2 incubator. After treatment, the
cells were centrifuged at 400× g for 5 min and the pellet was lysed
in Tri-Reagent (Molecular Research Center Inc., Cincinnati,
OH). Total cellular RNA was subjected to reverse transcription
using the reagents from Promega (Madison, WI). The real-time
PCR for the quantification of mRNA levels of IFN-γ and IL-
22 was performed with the iQ SYBR Green Supermix (Bio-
Rad Laboratories, Hercules, CA). The levels of glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) mRNA were used as an
endogenous reference to normalize the quantities of cytokine
mRNAs. For IFN-γ, primers are 5′-CCAAGTGATGGCTGA
ACTGTCG-3′ and 5′-TCTGACTCCTTTTTCGCTTCCC-3′. For
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IL-22, primers are 5′-TCCGCGGAGTCAGTATGAGTGAGC-
3′ and 5′-GAACCTATCCGATTGAGGGAGCAGC-3′. GAPDH
primers are 5′-GTCTGGAAAAACCTGCCAAG-3′ and 5′-ACC
TGGTGCTCAGTGTAGCC-3′.
Necropsy
Animals that reached the humane endpoints were euthanized
first by anesthesia with ketamine (i.m. 10mg/kg) and then by
an intravenous overdose of sodium pentobarbital (100mg/kg).
A full necropsy was performed to obtain lungs and other
organs under sterile conditions for microbiologic assays. A gross
pathology scoring system (Lin et al., 2006; Marsollier et al., 2007)
was used to quantitatively document TB lesions. The presence,
number, size and distribution of granulomas in tissues of infected
organs were documented.
Bacterial Burden
During the post-mortem, the tissues were randomly taken from
different organs (lung, bronchial lymph node (BrLN), liver,
spleen, kidney and pancreas) of the animals and examined for
bacterial burden. Samples were homogenized in 5 mL PBS by a
tissue homogenizer PRO250 (PRO Scientific, Monroe, CT). All
samples were serially 10-fold diluted in PBS prior to being plated
onto Middlebrook 7H11 medium (Difco, BD, USA) plus OADC
supplements (Difco) and cycloheximid (100 µg/mL; Sigma, St.
Louis, MO). After spreading the homogenate solution, plates
were incubated at 37◦C and counted for formed colonies 3–5
weeks after incubation.
Statistical Analysis
Data were analyzed using Prism6.0 (Graphpad Software, San
Diego, CA) and SPSS software (version 16.0, SPSS, Chicago,
IL, USA). Survival rates of the study animals were analyzed
by the log-rank test. The significant differences in the clinical
evaluations (appetite, body weight, body temperature, CRP and
ESR), SIV RNA levels and CD4/CD8 T cells ratios between two
groups were determined by the paired t-tests for area under the
curve (AUC) of each animal. Student t-tests were performed on
the differences in IFN-γ and IL-22 levels between two groups.
The grosspathology and the bacterial burden between two groups
were analyzed usingMann-Whitney test, p< 0.05 was considered
statistically significant.
RESULTS
SIV Facilitates Fatality of M.tb-Infected
Macaques
All co-infected animals reached the humane endpoints with
the survival time of 16 weeks (WSP1), 18 weeks (WSP3) and
19 weeks (WSP2) after M.tb infection, respectively (Table 1).
In contrast, M.tb mono-infected animals had longer survival
times than co-infected animals, as two of them survived 22
weeks (WSP9) and 25 (WSP8) weeks after M.tb infection,
respectively (Table 1). The third one (WSP7) had the high levels
of M.tb specific IFN-γ in PBMC (Figure 5C) and survived
throughout the course (31 weeks) of the study. During the
followed up (additional 24 months) this animal showed normal
appetite, increased body weight and normal chest X-ray (data not
shown). All SIV mono-infected animals did not develop AIDS or
opportunistic infections and survived through the course of the
study. Differences in survival times between co-infected andM.tb
mono-infected animals were statistically significant (P = 0.0246)
(Figure 1).
Effects of SIV and/or M.tb Infections on
Appetite, Body Weight, and Body
Temperature
Low grade fever, loss of appetite and weight are common
symptoms of M.tb infection in humans. Thus, we examined
these clinical parameters in the study animals. Following M.tb
infection, all co-infected animals and two M.tb mono-infected
animals (WSP8 and WSP9) exhibited loss of appetite and
body weight (Figures 2A,B). One M.tb mono-infected animals
(WSP7) exhibited only minor loss of appetite but little change
in body weight. Co-infected animals exhibited significant loss
of appetite and body weight than M.tb mono-infected group
(P = 0.0212 and 0.0473, respectively). The animal WSP02
developed a fever at week 3 after M.tb infection and reached
its highest level (1.4◦C higher than the base level) at week 6
after M.tb infection. The animal WSP03 developed a fever with
its maximum (1.8◦C higher than the base level) at week 8 after
M.tb infection. Two animals (WSP8 and WSP9) with mono-
infection had low grade fever (0.6 and 0.7◦C higher) at week
3 and week 6 (Figure 2C). Two (WSP2 and WSP3) co-infected
animals had a significant drop of body temperature at the late
stage of M.tb infection (Figure 2C). Co-infected animals had
significantly higher body temperatures at the early and middle
stage of M.tb infection (week 6 to week 18) than M.tb mono-
infected animals (P = 0.0052). In contrast, SIV mono-infected
animals had little changes of appetite, body weight and body
temperature (Figure 2).
FIGURE 1 | Survival of animals in M.tb mono-infected and co-infected
groups. For the coinfection experiments, the animals were intravenously (i.v.)
infected with SIVmac239 (TCID50 1.5 × 10
3) 6 weeks prior to inoculation by
intratracheal instillation (i.t.) of M.tb H37Rv (34 CFU) (arrow). M.tb
mono-infected animals were inoculated with the same dose of M.tb only. The
survival rates were analyzed by the Log-rank test. The survival times of
co-infected animals were significantly shorter (*P = 0.0246) than those of M.tb
mono-infected animals.
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FIGURE 2 | Clinical manifestations. (A) Weekly appetite score. Appetite was scored by the amount of food taken per meal (2 = all; 1 = about half; 0 = none). A
maximum appetite scores that an animal could achieve was 6 points per day and 42 points per week, which was defined as 100%. A percentage of the appetite
scores for each animal was calculated as weekly scores divided by 42. The appetite scores of co-infected animals were significantly lower (*P = 0.0212) than those of
M.tb mono-infected animals 6 to 26 weeks after M.tb infection. (B) Percentage change in body weight (every 2 or 3 weeks). The weight loss of co-infected animals
were significantly higher (*P = 0.0473) than that of M.tb mono-infected animals after M.tb infection (week 6 to week 26). (C) Changes in body temperature are
measured as changes in ◦C (every 2 or 3 weeks). The body temperatures of co-infected animals were significantly higher (**P = 0.0052) than those of M.tb
mono-infected animals 6 to 18 weeks after M.tb infection. Data are presented as individuals in each group. *i.t., intratracheal instillation of M.tb (34 CFU).
M.tb Mono-Infection or M.tb/SIV
Coinfection Increases ESR and CRP
ESR and CRP are two inflammatory markers in active M.tb
infection. As shown in Figure 3, two co-infected animals (WSP1
and WSP2) and allM.tbmono-infected animals showed elevated
levels of ESR during the course ofM.tb infection. All co-infected
animals and twoM.tbmono-infected animals (WSP8 andWSP9)
demonstrated elevated levels of CRP starting at week 12 after SIV
infection (Figure 3). WSP3 had normal ESR levels but abnormal
levels of CRP (Figure 3B). The levels of ESR and CRP were
not significantly different between co-infected and M.tb mono-
infected animals (P= 0.9861 and 0.5963, respectively) (Figure 3).
SIV mono-infected animals did not show elevated levels of ESR
and CRP (Figure 3).
M.tb Infection Has Little Impact on Plasma
SIV RNA and CD4/CD8 Ratio
To determine the impact ofM.tb on SIV infection, we measured
the plasma SIV RNA levels of co-infected animals and SIV
mono-infected animals. Plasma SIV RNAs were detected in all
co-infected and SIV mono-infected animals 2 weeks after SIV
infection. However, there was no significant difference (P =
0.1634) in viral RNA copies between co-infected and SIV mono-
infected animals during the course of infection (Figure 4A).
In addition, decreased CD4/CD8 ratios were observed in both
co-infected and SIV mono-infected animals (Figure 4B), but
there was little difference (P = 0.4427) between the two groups
(Figure 4B).
Effect of SIV Infection on M.tb Specific
IFN-γ and IL-22
IFN-γ is crucial in the host immunity against M.tb infection,
as it restricts mycobacterial proliferation in macrophages and
enhances CD8+ T cell-mediated CTL activity against M.tb-
infected target cells (Flynn et al., 1993; Cooper andKhader, 2008).
In addition to IFN-γ, IL-22 can also inhibit intracellular M.tb
growth in macrophages by enhancing phagolysosomal fusion
(Dhiman et al., 2009). Thus, we evaluated the expression of these
cytokines in PBMCs of M.tb-infected animals. PPD-stimulated
PBMCs from co-infected animals and M.tb mono-infected
animals expressed IFN-γ (Figure 5A) and IL-22 (Figure 5B).
However, the levels of PPD-induced IFN-γ and IL-22 mRNAs
were lower in two of co-infected animals than those in M.tb
mono-infected animals. The ELISpot assay also showed that two
co-infected animals had lower frequency of PPD specific IFN-
γ-secreting cells than M.tb mono-infected animals (Figure 5C).
However, because one (WSP1) of co-infected animals had high
levels of M.tb-induced IFN-γ and IL-22, differences in the levels
of these cytokines between two groups were not significant
(Figure 5). All SIV mono-infected animals lacked the PPD-
stimulated IFN-γ and/or IL-22 responses at both mRNA and
protein levels (Figure 5).
SIV Enhances M.tb Infection of Lungs and
Extrapulmonary Organs
Eight weeks afterM.tb infection, two (WSP8 and WSP9) ofM.tb
mono-infected animals showed abnormal chest X-rays. WSP8
had an area of consolidation in the right lower lobe, and WSP9
displayed an area of consolidation in the right middle lobe.
In contrast, all co-infected animals showed multiple pulmonary
nodules disseminated in the lungs. Fourteen weeks after M.tb
infection, among M.tb mono-infected animals, posteroanterior
chest X-rays of WSP8 showed areas of consolidation in the
right upper lobe and right middle lobe (Figure 6B). WSP9
showed consolidation of upper and middle lobes. However,
WSP7 remained a normal chest X-rays (Figure 6B). In contrast,
all co-infected animals had multiple patches and nodular
infiltrates distributed in both right and left lobes of lungs
with miliary (Figure 6A). In addition, necropsy of co-infected
animals revealed disseminated M.tb infections not only in
the lungs but also in the extrapulmonary organs, including
spleen, pancreas, liver, kidney and heart. The numbers of visible
nodules in the extrapulmonary organs (kidneys and livers) of
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FIGURE 3 | ESR and CRP levels. Peripheral blood was collected from the study animals at the indicated time points. The levels of Erythrocyte sedimentation rate
(ESR) (A), plasma levels of C-reactive protein (CRP) (B) were measured. *i.t., intratracheal instillation of M.tb (34 CFU).
FIGURE 4 | Plasma SIV RNA levels and CD4/CD8 T cell ratios in PBMCs. (A) Plasma SIV RNA copies were determined by the real time PCR with the primers of
SIV GAG gene. The data shown are the means of plasma SIV RNA copies/mL of animals in two groups. (B) Flow cytometry analysis of CD4+ and CD8+ T cells in the
peripheral blood. The data shown are the means of CD4/CD8 T cell ratios in PBMCs of three animals in two groups. (C,D) The means of SIV RNA levels (C) or
CD4/CD8 ratios (D) in each group. The P-values of the parameters are indicated. *i.t., intratracheal instillation of M.tb (34 CFU).
co-infected animals were higher than those of M.tb mono-
infected animals (Figures 7A, 8). In addition, the bacterial counts
in the lungs, BrLN and extrapulmonary organs (liver, kidney,
heart, spleen) of co-infected animals were significantly higher
than those of M.tb mono-infected animals (P = 0.0286 and
0.0037, respectively) (Figures 7B,C, and Supplementary Table 1).
Except for one M.tb mono-infected animal (WSP7), all other
five animals showed histopathologic evidence of extensive M.tb
infection and caseous necrosis in the lungs. SIV/M.tb co-infected
animals exhibited disseminated and more severe M.tb infection
(appearance of granulomas) in multiple organs thanM.tbmono-
infected animals (Figure 8).
DISCUSSION
TB is one of the most common opportunistic infections for
people infected with HIV, even when CD4 cells count and
antiretroviral therapy are taken into account (Suchindran et al.,
2009). Because people with HIV/AIDS carry a high risk of
M.tb infection and disease severity, it is clinically significant
to have an experimental animal model that mimics M.tb and
HIV coinfection. However, unreliable and limited animal models
restrict the research on HIV and M.tb coinfection. Macaques
have been widely used for HIV/AIDS research as they can be
infected by SIV (Zhou et al., 2013). In addition, cynomolgus
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FIGURE 5 | Effect of M.tb and/or SIV infections on M.tb specific IFN-γ and IL-22. PBMCs from the study animals were cultured in the presence of PPD,
(10 µg/mL) for 16 h. Total RNAs were extracted and the expression of IFN-γ (A) and IL-22 (B) was measured by the real-time PCR at different time points (6 week, 10
week and 16 week after M.tb inoculation). The levels of IFN-γ and IL-22 mRNAs were expressed as fold changes of medium alone (control value = 1). The levels of
IFN-γ and IL-22 mRNAs were not significantly different between co-infected and M.tb mono-infected animals (P > 0.05). IFN-γ ELISpot assay was performed in the
presence of PPD as described in Materials and Methods. (C) The graphic representation of quantified numbers of PPD-induced IFN-γ spots are shown as
SFU/1 × 106 cells. The number of PPD-induced IFN-γ spots were not significantly different between co-infected and M.tb mono-infected animals (P = 0.4669).
FIGURE 6 | Chest X-rays of co-infected and M.tb mono-infected animals. Chest radiographs of co-infected and M.tb mono-infected animals at 14 weeks after
M.tb infection. The red arrows indicate the positions of patchy nodular areas in lungs.
and rhesus macaques are the host for M.tb infection (Walsh
et al., 1996; McMurray, 2000; Verreck et al., 2009). Therefore,
the macaques represent a suitable animal model for either
SIV or M.tb infection. However, there are limited studies that
used the macaque models to study SIV and M.tb coinfection.
Those studies (Safi et al., 2003; Diedrich et al., 2010; Mehra
et al., 2011) using cynomolgus or rhesus macaques of Indian
origin demonstrated that rhesus macaque is a suitable model
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FIGURE 7 | Gross pathologic evaluation of TB granulomas and bacterial burdens in lungs and extrapulmonary organs of M.tb mono-infected and
co-infected animals. (A) The pathological scores were calculated based on the size and frequency of TB granulomas in the lungs, livers, spleens and kidneys. (B)
The bacterial burdens in the lung and bronchial lymph node (BrLN) of co-infected animals are significantly higher (*P = 0.0286) than those of M.tb mono-infected
animals. (C) The bacterial burdens in the extrapulmonary organs (liver, spleen, kidney, and pancreas) of co-infected animals were significantly higher (**P = 0.0037)
than those of M.tb mono-infected animals.
FIGURE 8 | Gross morphological pathology of extrapulmonary organs of the study animals. A few granulomas were observed in spleen (A) and kidneys (C),
while no visible lesions in liver (B) and heart (D) of M.tb mono-infected animal (WSP8) at necropsy. A number of granulomas were observed in the spleen (E), liver (F),
kidneys (G), and heart (H) of co-infected animal (WSP3) at necropsy.
to study SIV and M.tb coinfection. It is unclear, however
whether macaques of Chinese origin can be used for SIV
and M.tb coinfection studies. Although Chinese macaques and
Indian macaques belong to the same species, they demonstrate
differences in physiological and immunological responses, as
well as genetic background (Champoux et al., 1997; Clarke and
O’Neil, 1999; Viray et al., 2001; Doxiadis et al., 2003; Penedo
et al., 2005; Otting et al., 2007). Therefore, it is of importance and
interest to examine the feasibility of using Chinese macaques for
SIV andM.tb coinfection.
To mimic clinical situation where HIV-infected individuals
are susceptible to M.tb infection and develop severe TB disease,
we first infected the animals with SIV for 6 weeks prior to
M.tb inoculation. Because Chinese rhesus macaques are highly
susceptible to M.tb Erdman strain infection, developing acute
TB disease regardless of the challenging doses (Zhang et al.,
2014), we used M.tb H37Rv strain to infect the animals. We
found that all co-infected and two out of three M.tb mono-
infected animals developed the end-stage of disease. Compared
to M.tb mono-infected animals, co-infected animals reached to
the humane endpoint faster (Figure 1). At necropsy, we observed
a number of granulomas in the lungs of co-infected and M.tb
mono-infected animals. There were no significant differences
in the pathologic scores of the lungs between the two groups
(Figure 7A). This observation could be due to the fact that the
animals in both groups developed acute/severe M.tb infection,
resulting in extensive lung damages. However, chest X-rays
showed that co-infected animals had disseminatedM.tb infection
in both right and left lungs (Figure 6), whileM.tbmono-infected
animals had the infection limited in their right lungs (Figure 6).
In addition, co-infected animals had more granulomas in the
extrapulmonary organs (kidneys and livers) than M.tb mono-
infected animals (Figure 7A). Interestingly, a granuloma was
found in the heart of a co-infected animal (WSP3) (Figure 8).
The bacterial burdens in the lungs, BrLNs and extrapulmonary
organs (liver, kidney, heart, spleen) of co-infected animals were
significantly higher than those of M.tb mono-infected animals
(Figures 7B,C; Supplementary Table 1). In addition, co-infected
animals survived shorter time thanM.tbmono-infected animals.
These findings indicate that SIV infection results in the spread
of M.tb, leading to disseminated M.tb infection in multiple
organs of co-infected animals. Interestingly, our data (Figure 4)
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showed that M.tb infection had little impact on SIV infection,
as there were little differences in the viral loads and CD4/CD8
ratios between co-infected and SIV mono-infected animals. Shen
et al. showed that BCG coinfection enhanced the destruction
of CD4+ T cells in SIV-infected macaques whose viral loads
were high (Shen et al., 2002). This discrepancy could be due
to the differences in M.tb strains, SIV strains and macaque
species (Rhesus, Pigtailed vs. Chinese rhesus) used in the studies.
Evidently, more studies with large numbers of macaques are
needed in order to draw the conclusion.
Whilst HIV/SIV-mediated immunological impairments are
likely to contribute to the increased morbidity and mortality
associated with M.tb infection, it is unclear, however, HIV/SIV
impair specific anti-TB immunity. To determine the specific
mechanisms for SIV infection-mediated enhancement of M.tb
infection, we examined two key cytokines (IFN-γ and IL-22)
that have the ability to inhibit M.tb infection (Luciw et al., 2011;
Mehra et al., 2011, 2012; Dutta et al., 2012). IFN-γ is well known
to have a key role in the immune defenses againstM.tb infection.
The early study showed that persons with genetic defects and
reduced production of IFN-γ or failure to respond to IFN-γ
develop severe and fatal mycobacterial disease (Safi et al., 2003).
IL-22-producing cells at mucosal surfaces play a crucial role
in the host innate defense against microorganisms, including
M.tb (Aujla and Kolls, 2009). A recent report showed that IL-
22 can inhibit the growth of M.tb in macrophages by enhancing
phagolysosomal fusion (Dhiman et al., 2014). In addition, the
IL-22-producing T cell-mediated immunity is important for
the protective anti-M.tb response (Bhuju et al., 2012). IL-22 is
mainly produced by IFN-γ-secreting cells but is dispensable for
host protection against M.tb infection (Behrends et al., 2013).
There is a reciprocal relationship between IFN-γ and IL-22
production by IL-22 and IFN-γ-producing CD4+ T cells (Qiu
et al., 2013). We found that the levels of the M.tb specific IL-
22 were significantly lower in two of co-infected animals than
those in M.tb mono-infected animals (Figure 5B). In addition,
the productions of M.tb specific IFN-γ were also suppressed in
two co-infected animals (Figure 5C). These findings, however,
need to be confirmed in future studies with large number of
animals.
In summary, we demonstrated that Chinese macaque is a
suitable and alternative NHP model for SIV/M.tb coinfection
studies. With limited number of animals, we observed that
while M.tb had little impact on SIV infection, SIV infection
accelerated M.tb dissemination in multiple organs, including
heart in co-infected animals. The impairment of the specific
anti-TB immunity is likely to be a key contributor of SIV-
mediated M.tb dissemination. However, further investigations
on interactions between HIV/SIV andM.tb are necessary, which
should improve and advance our knowledge about treating HIV
andM.tb co-infected individuals.
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